Resistant organisms and otitis media.
Dagan
Ron
R
Regev-Yochay
Gili
G
Rubinstein
Ethan
E
D000208:Acute Disease; D000658:Amoxicillin / Q000627:therapeutic use; D000900:Anti-Bacterial Agents / Q000627:therapeutic use*; D017963:Azithromycin / Q000627:therapeutic use; D002443:Ceftriaxone / Q000627:therapeutic use; D002511:Cephalosporins / Q000627:therapeutic use; D024901:Drug Resistance, Multiple, Bacterial; D006801:Humans; D008826:Microbial Sensitivity Tests; D010033:Otitis Media / Q000188:drug therapy* / Q000382:microbiology*; D018570:Risk Assessment; D012680:Sensitivity and Specificity; D013296:Streptococcus pneumoniae / Q000187:drug effects* / Q000302:isolation & purification; D000097670:Cefprozil
D000658:Amoxicillin; D000900:Anti-Bacterial Agents; D017963:Azithromycin; D002443:Ceftriaxone; D002511:Cephalosporins; D000097670:Cefprozil